Skip to main content
SNAP Update and Resources Actualización y recursos de SNAP

On November 1, 2025, the requirements to receive and apply to the Supplemental Nutrition Assistance Program (SNAP) benefits have changed. To see the new policies to request SNAP benefits, click here and/or call 211 for SNAP assistance. Learn more

El 1 de noviembre de 2025, cambiaron los requisitos para recibir y aplicar para los beneficios del Programa de Asistencia Nutricional Suplementaria (SNAP, por sus siglas en inglés). Para consultar las nuevas políticas para aplicar para los beneficios de SNAP, haz clic aquí o llama al 211 para obtener ayuda de SNAP. Aprende Más

Transportation Update Actualización de transporte

Starting December 15, 2025, SafeRide Health will become the new provider for all member rides to doctor appointments and pharmacy visits. After this date, Texas Children’s Health Plan will no longer use MTM for Non Emergency Medical Transportation (NEMT) services.

Learn more here

For other questions, please call Member Services at the number on the back of your member ID card.

A partir del 15 de diciembre de 2025, SafeRide Health será el nuevo proveedor para todos los viajes de los miembros a citas médicas y visitas a la farmacia. Después de esta fecha, Texas Children’s Health Plan ya no usará MTM para los servicios de Transporte Médico No Urgente (NEMT).

Obtenga más información AQUI

Si tiene otras preguntas, llame a Servicios para Miembros al número que aparece en la parte posterior de su tarjeta de identificación del miembro.

Implementation of Hormonal Therapy Agents Clinical Prior Authorization

Date: May 28, 2024
Attention: All Providers

Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that on May 17, 2024 Health and Human Services Commission (HHSC) published an updated Hormonal Therapy Agents Clinical prior authorization criteria guide that was originally implemented on March 1, 2024.

Previous TCHP provider alerts on hormonal therapy agents:

Clinical Implementation of Hormonal Therapy Agents Clinical Prior Authorization Effective March 1, 2024: https://www.thecheckup.org/2024/02/02/provider-alert-clinical-implementation-of-hormonal-therapy-agents-clinical-prior-authorization-effective-march-1-2024/

Clinical Criteria Implementation for Enzyme Replacement Hormonal Therapy Agents effective May 1, 2024: https://www.thecheckup.org/2024/04/18/provider-alert-clinical-criteria-implementation-for-enzyme-replacement-hormonal-therapy-agents-effective-may-1-2024/

How this impacts providers: May 17, 2024 updates include the following.

  • Adding GCNs for:
    • Methitest (10411)
    • Oxandrolone (10561, 18265)
    • Synarel (84354)
    • Testosterone Cypionate (10194, 10191)
    • Lyllana (28840, 28841, 28842, 28843, 28846)
    • Alora (28840, 28841, 28842, 28843)
    • Minivelle (28840, 28841, 28842, 28843, 28846)

  • Correcting GCN for:
    • Kyzatrex from 52948 to 52648

  • Removing GCN for:
    • Lupron Depot-Ped 45 mg 6mo kit (54034)

Next step for Providers: Providers are strongly encouraged to follow the guidance as specified above. Prescribers should share this communication with their staff. Providers must stay up-to-date on the latest restrictions and indications for these agents to ensure appropriate use and maximize patient outcomes. Provider must submit documentation (such as office chart notes, lab results, other pertinent clinical information, etc.) supporting that the member has met all appropriate criteria for medication approval.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.